Herbas VPB

Print
EN | LT
LT - Indazolo junginiai ir farmacinės kompozicijos proteinkinazių slopinimui, ir jų panaudojimo būdai
EN - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Legal status

Patent expired

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 231/56 (2006.01)
C07D 403/04 (2006.01)
C07D 417/12 (2006.01)
C07D 405/06 (2006.01)
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 413/12 (2006.01)
C07D 401/04 (2006.01)
C07D 417/14 (2006.01)
C07D 401/14 (2006.01)
C07D 405/14 (2006.01)
C07D 403/14 (2006.01)
C07D 409/06 (2006.01)
C07D 409/12 (2006.01)
C07D 401/06 (2006.01)
C07D 409/14 (2006.01)
C07D 471/04 (2006.01)
A61K 31/416 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 1614683
(13) Kind of document T
(96) European patent application number 05015902.9
Date of filing the European patent application 2000-06-30
(97) Date of publication of the European application 2006-01-11
(45) Date of publication and mention of the grant of the patent 2007-11-21
(46) Date of publication of the claims translation 2008-02-25
Priority applications
(30) Number Date Country code
142130 P 1999-07-02 US
Inventors
(72)
Collins, Michael Raymond, US
Tempczyk-Russell, Anna Maria, US
Hua, Ye, US
Johnson, Michael David, US
Bender, Steven Lee, US
Kania, Robert Steven, US
Borchardt, Allen J., US
Braganza, John F., US
Cripps, Stephan James, US
Johnson, Theodore Otto Jr., US
Luu, Hiep The, US
Palmer, Cynthia Louise, US
Reich, Siegfried Heinz, US
Teng, Min, US
Thomas, Christine, US
Varney, Michael David, US
Wallace, Michael Brennan, US
Grantee
(73) Agouron Pharmaceuticals, LLC, 10646 Science Center Drive, San Diego, California 92121, US
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Indazolo junginiai ir farmacinės kompozicijos proteinkinazių slopinimui, ir jų panaudojimo būdai
  Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Last renewal fee
Payment date Validity (years) Amount
2019-06-18 20 347.00 EUR